Navigation Links
PARI Pharma Enrolls First Patient in Phase 2b Study of L-CsA
Date:2/11/2010

MONTEREY, Calif., Feb. 11 /PRNewswire/ -- PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System.  The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.

"We are very pleased to move forward with this investigational treatment aimed at preventing bronchiolitis obliterans, which is an incurable small airway disease in lung transplant recipients.  This study has been designed with advice from the European Medicines Agency under L-CsA's orphan drug designation status," said Manfred Keller, chief scientific officer and executive vice president of PARI Pharma.

PARI Pharma's Phase 2b trial is a multi-center, randomized, double-blind, placebo controlled, parallel group, dose-finding study to investigate the safety and efficacy of L-CsA in doses of 10mg/day and 20mg/day to prevent bronchiolitis obliterans in recipients of lung transplants.

"We are seeing early success from our L-CsA program. This underscores PARI Pharma's unique position to combine formulation expertise with our advanced aerosol delivery technology to develop best in class therapies for unmet medical needs," added Martin Knoch, president of PARI Pharma.

Positive data regarding human lung deposition and distribution of L-CsA was published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery last year, and clinical as well as preclinical data will be presented in April at the Annual Meeting of the International Society of Heart and Lung Transplantation in Chica
'/>"/>

SOURCE PARI Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
(Date:1/14/2014)... , January 14, 2014 ... Transfer Devices (CSTD) for hazardous drugs, today announced that it ... fourth straight year.   Equashield,s closed ... technicians, pharmacists, nurses and other medical professionals who ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... Calif., Dec. 7, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... the company,s president and chief operating officer, is scheduled ... Annual Healthcare Conference in New York City on Wednesday, ... (Logo: http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) To ...
... 7, 2011   Talyst has released an updated ... The bar code technology ensures virtually 100% of medications ... The improved AutoLabel is a complete ... and white transfer labels to improve patient safety at ...
Cached Medicine Technology:Talyst Updates Its AutoLabel® Solution 2
(Date:4/22/2014)... The risk of pregnancy among women using a newer ... than 10 times greater over a 10-year period than ... by researchers at Yale University and UC Davis has ... journal Contraception , the study found the higher ... under the brand name Essure. , "This study ...
(Date:4/22/2014)... The International Communication Association will hold its 64th ... theme of the 2014 conference will explore what ... digital society. , Featuring over 2,300 academic papers ... scholars representing over 40 countries, the ICA conference ... the world. This year,s conference features sessions that ...
(Date:4/22/2014)... the standard measurement for assessing glycemic control over time ... typically measured every few months in a laboratory, but ... estimates A1c using self-monitored blood glucose (SMBG) readings, as ... DTT ), a peer-reviewed journal from Mary Ann Liebert, ... DTT website at http://www.liebertpub.com/dtt . , ...
(Date:4/22/2014)... Sophia Antipolis, 22 April 2014. The latest scientific advances ... at Heart Failure 2014, the main annual meeting of ... of Cardiology (ESC). Journalists will also hear breaking news ... on Acute Heart Failure, which is part of the ... May in Athens, Greece, at the Megaron Athens International ...
(Date:4/22/2014)... developed at the University of Utah (U of U) ... three separate cases, U of U researchers and their ... American Journal of Human Genetics . The software, Phevor ... and unknown gene mutations by analyzing the exomes, or ... are made, in individual patients and small families. ...
Breaking Medicine News(10 mins):Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3
... heart attack and stroke, increases with high blood glucose, ... these values to ideal levels. According to researchers at ... be as simple as seeing your doctor. They found ... of blood glucose, blood pressure and cholesterol treatment goals. ...
... People may be learning while they,re sleeping ... well understood, according to a study by Michigan State ... Journal of Experimental Psychology: General. "We speculate that ... distinct from traditional memory systems," said Kimberly Fenn, assistant ...
... research shows liver transplantation candidates without hepatocellular carcinoma (HCC) ... liver transplant (LDLT) than waiting for a deceased donor ... October issue of Hepatology, a journal published by Wiley-Blackwell ... of Liver Diseases, reports that survival benefit from LDLT ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Sept. 26 ... or more cups of caffeinated coffee daily seem to have a ... stop at one cup a day, a new study suggests. ... as a way to prevent depression, the findings may comfort those ...
... livestock farms cause asthma and COPD patients living nearby ... at the European Respiratory Society,s Annual Congress in Amsterdam. ... and goat farms increased with the number of animals ... found, hinting at higher health risks from ,mega farms,. ...
... Media have less than three weeks to register ... Multidisciplinary Cancer Congress in Stockholm, 23-27 September 2011. ... European Multidisciplinary Cancer Congress will take place at ... www.stofair.se ) from Friday 23 September to Tuesday ...
Cached Medicine News:Health News:Frequent doctor visits benefits patients with diabetes 2Health News:Living donor liver transplantation improves survival over deceased donor transplants 2Health News: Lots of Coffee Might Lower Depression Risk: Study 2Health News: Lots of Coffee Might Lower Depression Risk: Study 3Health News:Environmental health risks of livestock farming 2Health News:Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011 2Health News:Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011 3
... INSTAT Collagen Absorbable Hemostat is a purified ... prepared as a sponge-like pad, is lightly ... which is an inherent property of collagen, ... structure of this protein. The helical structure ...
... Microspin centrifuge offers reliable microhematocrit determinations. Although ... it is more affordable than most competitive ... assures rapid spin-downs, and the included reader ... variety of circumstances. Offering quieter operation than ...
... international engineering and design specifications, Smith ... System* provides seamless integration with existing ... open reduction internal fixational procedures (AO ... well beyond the standard, providing a ...
... of the most technically demanding specialties within ... offers the highly specialized surgeon a complete ... the pelvis and acetabulum. , ,Joel ... pelvic surgeon, is the designer of this ...
Medicine Products: